|Publication number||USRE39334 E1|
|Application number||US 09/699,398|
|Publication date||Oct 10, 2006|
|Filing date||Oct 31, 2000|
|Priority date||May 25, 1994|
|Publication number||09699398, 699398, US RE39334 E1, US RE39334E1, US-E1-RE39334, USRE39334 E1, USRE39334E1|
|Inventors||Lawrence A. Lynn|
|Original Assignee||Lynn Lawrence A|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (65), Non-Patent Citations (2), Referenced by (22), Classifications (18), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
**NOTICE: More than one application for Reissue of U.S. Pat. No. 5,549,651 has been filed. This Reissue Application is a Continuation of Reissue application No. 09/140,413 filed Aug. 26, 1998, now U.S. Pat. No. RE 37,357.
The risk of needlestick injury and the expense associated with accessory cannulae, whether blunt or sharp, are well known. Conventional intravenous tubing systems utilize tapering luer male cannula connectors, often within an associated surrounding threadable member defining a luer-lock connector commonly used for achieving tight sustained connections. A bare luer taper cannula without the associated threadable member is commonly called a luer slip connector and is widely utilized for brief prn injections. Both of these luer systems are in wide use throughout conventional hospital systems and it would be preferable to develop a connecting valve system which receives and is activated by conventional luer slip tapers or luer lock tapers so that incorporation into existing hospital systems is rapid and associated with minimal cost. It would be advantageous for such systems to avoid deadspace so that the surface could be easily wiped with antiseptic to avoid the need for capping after each use. Furthermore, the elimination of deadspace allows for the aspiration of blood through such systems without the collection of blood within the deadspace. Another important feature of such systems is the minimization of “kickback”—that is, it is important that the luer slip tip or luer lock systems, when not tightly locked, do not kickback out of the valve, thereby producing the potential for a spurt of blood or fluid into the environment and potential contamination of the operator. The prior art includes several luer-receiving valves which do not have substantial deadspace. U.S. Pat. No. 5,201,725 discloses shows a valve which utilizes an elastomeric member which opens by force induced by a threadable member over the elastomeric septum piston. Such a system will not work with a conventional luer lock system since the male taper extends centrally adjacent the luer lock threading member and therefore, it would not be possible to compress the septum piston within the luer-lock threads in such a system without inserting the male member itself into the septum piston. The background discussed in the aforementioned patent provides additional background for the present invention.
A device, designated the CLAVE™, for an injection port marketed by McCaw, is included in the Prior Art. This device utilizes a cannula surrounded by a septum piston. The septum piston is compressed by the luer taper, thereby allowing the needle and its associated bore to enter the bore of the luer taper, thereby opening fluid communication. However, such systems would be expected to be associated with substantial kickback when used with a luer slip system since the septum piston must be relatively resilient to prevent leakage associated with higher fluid pressures within the cannula. Further, the requirement of a spike or cannula within the bore of the valve results in considerable increase in expense associated with complex insert molding of the device. It is, therefore, preferable to develop a more simplified valve system which can receive a luer taper cannula and which eliminates the need for complex insert molding to minimize the potential for kickback and the potential for trapped fluid or blood while still providing a deadspace-free surface which can be easily wiped with antiseptic.
In general, the present invention comprises a housing including a main conduit having a main bore and further having a branch extending away from the main conduit and including a secondary bore extending through the branch in fluid communication with the main conduit. The secondary bore may be aligned directly with the main conduit or may branch from the main conduit. The main conduit may, for example, comprise a catheter or may be a primary intravenous tubing system or arterial line. The secondary bore defines a longitudinal axis. An elastomeric septum piston is disposed within the secondary bore and at least a portion of the elastomeric septum piston is moveable by either compression or by longitudinal advancement along the secondary bore toward the main bore. In one preferred embodiment, the septum piston is cylindrical and includes a centrally positioned slit extending along the longitudinal axis of the cylindrical septum piston. The cylinder includes a proximal end and a distal end. The proximal end preferably extends to a position adjacent the proximal end of the secondary bore so that the surface of the proximal end of the septum piston is easily accessible adjacent the proximal end of the branch and therefore can be easily wiped with antiseptic. This is an important feature since it eliminates the need for capping after blood aspiration or drug injection. The bore of the secondary branch preferably includes two opposing projecting members along a distal portion of the bore which effectively narrow the diameter of the bore along at least a portion of one longitudinal axis. In the preferred embodiment, the central slit through the septum piston defines a longitudinal axis transverse to the longitudinal axis of the septum piston. With this embodiment, the longitudinal plane of the narrowed distal portion of the secondary bore is aligned with the longitudinal axis of the slit through the elastomeric septum piston. Furthermore, the elastomeric septum piston is sized to be transversely compressed by the projecting distal portions of the secondary bore. Since the slit is aligned with the projecting portions, transverse compression of the septum piston occurs along an axis which corresponds with the longitudinal axis of the slit so that when the elastomeric member is pushed from a proximal position into a distal position, the elastomeric member is transversely compressed by the projecting portions along the distal secondary bore, the compression causing the formerly tightly-closed slit to shorten and thereby open, allowing fluid to pass through a nascent flow channel formed by the shortened slit through the elastomeric septum piston. When the septum piston retracts away from the distal portion back into the proximal portion, the slit returns to its tightly closed position, thereby occluding further fluid communication through the septum piston.
In the preferred embodiment, the projecting portions progressively lengthen to define a progressively decreasing distance between the projecting members so that the projecting members are closer to one another adjacent the main bore than adjacent the proximal cylindrical portion of the secondary bore. This effectuates a progressive enlargement of the opening through slit of the elastomeric septum piston when the elastomeric septum piston is fully advanced into the proximal portion of the secondary bore. Furthermore, after removal of the luer, as the elastomeric septum piston retracts away from the distal compressing portion toward the proximal portion, the slit progressively closes from its proximal extent toward its distal extent, thereby expressing fluid toward the main bore rather than toward the proximal opening of the secondary bore. This reduces the chance of blood or fluid refluxing out of the septum piston into the environment or into the secondary bore when luer taper cannula is withdrawn from the secondary bore. The branch of the main conduit can be aligned directly with or perpendicular to the main conduit or can be at an oblique or acute angle with the main conduit. The main conduit is generally discussed below as integral with the valve, but the main conduit may be a separate piece and sold separately, and may be joined with the branch or the aligned secondary bore by a threadable member as, for example, joining a conventional heparin well or prn adapter to a catheter, stopcock, or IV tubing system. The branch preferably includes at least one external thread or thread receiver for receiving an internal female threading member to allow a secure threaded connection with a conventional luer-lock type connector of the type commonly used with conventional syringes or intravenous tubing systems. The use of this luer-activated valve in association with IV piggyback administration generally would require the recapping of the luer taper after use so that the luer taper remains sterile between IV piggyback mediation administrations. My U.S. Pat. No. 5,167,643 (the disclosure of which is hereby incorporated by reference as if completely disclosed herein) describes a Docking Station for receiving a blunt cannula such as a tapered luer end to maintain the sterility of the tapered end. The present invention includes the secondary tubing system having a docking station intended for use with a conventional luer taper cannula of the slip tip or luer lock type. This station utilizes a simple membranous cover since the primary function of the cover is to cover and seal the luer within the station, as discussed in the previous patent. The new protection station may include an annular shield for protecting the fingertips against inadvertent contact of the luer taper since the luer taper has been removed from fluid connection with the patient's blood vessel and, therefore, could be contaminated by potentially infectious material which, by even surface contamination of a nurses fingers, could subsequently enter a fissure in the fingers or otherwise be transferred to a mucous membrane where infection could ensue. The station preferably includes a connecting portion for connecting to a proximal portion of the intravenous piggyback system or supporting pole, as described in my aforementioned patent. The combination of a primary fluid system which incorporates a luer-activated valve and a secondary system which incorporates a luer cannula protection station which protects the tapered blunt cannula of the luer provides reliable intermittent connection to the patient with assurance that the luer taper remains sterile between use and eliminates the need for the utilization of multiple caps, thereby reducing overall cost.
It is the purpose of the present invention to provide an inexpensive medical valve which can be activated by a conventional luer taper cannula and thereby be widely implemented within existing hospital systems.
It is further the purpose of this invention to provide a medical valve which can be easily wiped with antiseptic to eliminate the need for recapping after use. It is further the purpose of this invention to provide a medical valve having substantially no deadspace adjacent its proximal portion to eliminate the pooling of blood or liquid within the valve so that the valve may be repetitively used for the aspiration of blood and reinjection of liquids. It is further the purpose of this invention to provide a luer-activated opening of a central fluid path which is automatically aligned with the bore of the luer and which will directly communicate with the bore of a luer taper cannula upon the transmission of longitudinal force of the luer taper cannula against the septum piston, thereby providing a mechanism for the opening of a centrally-positioned fluid path at the same time tight sealing occurs adjacent the distal end of the luer taper cannula against the septum piston. It is further the purpose of this invention to provide a valve which progressively closes from its proximal extent to its distal extent, thereby expressing residual fluid from the valve away from the environment. It is further the purpose of this invention to provide a two-piece valve which can be simply manufactured by the insertion of an elastomeric septum piston into a rigid tubular structure, thereby avoiding the need for expensive and complex insert molding.
These and other features will become evident from the summary and detailed description described below. Furthermore, these and other objects and advantages of the invention will be further set forth in the description which follows and, in part, will be learned from the description or may be learned by practice of the invention. The objects and advantages of the invention may be realized by means of the instrumentalities and combinations particularly pointed out in the appended claims.
The luer tapered cannula receiving valve 5 (
In the preferred embodiment, a silicone lubricant is provided to enhance the sliding piston-like action of the sealingly received septum piston 60 against the side walls 42 and 46 of the cylinder 18. As noted previously, the slit 72 extends completely through the cylindrical septum piston 60. The long transverse axis of the slit 72 (in the transverse plane of the septum piston) is aligned within the same plane as the longitudinal axis through the opposing projecting members 50 of the distal bore portion 38 (FIG. 1). Furthermore, the transverse diameter of the distal bore portion along an axis perpendicular to the longitudinal plane of the projecting members 50 can be slightly greater than the transverse diameter of the septum piston 60 to thereby, during operation, receive a bulging portion of the septum piston 60, as will be discussed.
A septum wiper 78 is provided and a bore detent 80 is provided to retain the elastomeric septum piston 60 within the secondary bore by receiving the septum wiper. The wiper 78 is flexible to provide a tight seal. A second wiper (not shown) can be provided adjacent the proximal end 62 to provide additional sealing. The wiper 78 includes a partial recess 79 for receiving the projecting members 50 to allow tight sealing when passing over the members 50. After insertion, during manufacture, the septum detent wiper 78 engages the detent 80. As shown, the septum wiper 78 is configured so as to allow distal displacement of the septum piston 60 out of its detented position (of FIG. 1), but to prevent proximal bore displacement of the septum piston 60 out of its detented position.
In operation, when a connection, injection, or aspiration is required, a conventional luer taper cannula 35 having a central opening 94 is inserted into the proximal bore portion 34 of the cylinder 18. Advancement of the luer taper cannula 35 causes longitudinal displacement of the septum piston 60 from within the proximal bore portion 34 into the distal bore portion 38 between the projecting portions 50. This causes compression of the septum 60 in an axis which is aligned with the long transverse axis of the longitudinal slit 72 so that the slit is transversely shortened, and thereby opened to define an open fluid flow channel 100. The formerly cylindrical septum piston 60 is narrowed in one transverse axis and bulges and widens in the perpendicular transverse axis, thereby producing an ellipse with a shortened and now opened central slit 72 (FIG. 2 and FIG. 5), although the actual configuration within the cylinder may be limited in situ by the cylinder wall 46. As noted previously, the projecting members 50 progressively enlarge to progressively narrow the width of the distal portion 38 between the projecting members 50. If the elastomer is soft, this will cause the slit 72 to progressively shorten from its proximal extent toward its distal extent and, therefore, the flow channel 100 will be narrower in the proximal extent and wider toward the distal extent. If the elastomer is comprised of a harder elastomer such as high durometer silicone, for example, exceeding 60 durometer-A medical grade), then the slit 72 will be wedged widely open along its entire length.
After the injection or aspiration is complete, the luer taper cannula 35 is withdrawn from the proximal portion 34 of the cylinder 18. Upon removal of the luer taper cannula 35, the septum piston 60 rebounds gently from its formerly advanced position back into its proximal sealing position with the proximal end of the septum piston returning to a position adjacent the proximal end 30 of the cylinder 18. The lubrication of the septum piston 60 and the progressive narrowing of the opposing members 50 causes the resilient septum piston 60 to rebound back from its advanced position. By using a slowly progressive taper, the force of the rebound can be minimized to prevent kickback of the luer 35 from the proximal portion 34 of the cylinder 18. In addition, an umbrella, as will be discussed, could be attached so as to provide less redundancy and, therefore, to provide elastic rebound. As discussed previously, during the return of the septum piston 60 back toward its resting position, the flow channel 100 can progressively close from its proximal extent to its distal extent to effectively express any liquid contained within the flow channel 100 back toward the main bore 10, rather than out toward the cylinder 18.
It can be seen that, by utilizing the achievement of lateral compression by the application of longitudinal displacing force against the septum piston, the rebound force of the septum piston is minimized. In other words, despite the fact that the valve is engaged by longitudinal force of the luer taper, the valve is actually opened by lateral compressive force of the cylinder wall or projecting members, rather than the directly applied activating longitudinal force. Therefore, it is not necessary to have a high resisting longitudinal rebound force to achieve and maintain a tight seal. For this reason, it is not necessary for this valve to utilize a deadspace filler of the type described in my U.S. Pat. No. 5,178,607, as will be discussed later. However, the implementation of deadspace displacement or filler provides an opportunity for utilization in valve, septum piston, or piston configurations wherein deadspace is present and wherein it is desirous to eliminate this deadspace so that recapping is not necessary.
Another similar septum piston embodiment, as shown in
In another septum piston embodiment (FIGS. 7 and 8), a projecting main bore occluding member 102′ is provided adjacent the distal end of the septum piston 60′. The occluding member 102′ includes a circular distal end 104′ and is sized to be sealingly received into the main bore 10 when the septum piston 60′ is advanced. For operation of this embodiment, the cylinder 18 is preferably positioned at an angle relative to the main housing 10 and the secondary bore 22 intersects the main bore 10 at an angle which may be 30°-900° (as in FIG. 1). The main bore 10 is connected distally to a distal conduit which is in fluid connection with a patient's blood vessel. The main bore 10 is connected proximally to a proximal conduit which is in fluid connection with a primary fluid source, such as a high pressure flush bag or a bag of intravenous fluid. The operation of this embodiment is similar to the aforementioned embodiment; however, the occluding member 102′ extends distally upon advancement of the septum piston 60′ so that the occluding member 102 ′ passes the flow deflector 110 ′ and occludes the main bore 10 adjacent the cylinder 18 in a position intermediate the cylinder 18 and the primary fluid source. This embodiment provides closure of fluid connection between the secondary bore 22 and the primary fluid source, as well as between the patient and the primary fluid source during either aspiration or injection of fluid from the secondary bore 22. This embodiment, therefore, functions to open communication between the opening 94 of the luer 35 and the patient through the septum piston 60 ′ and the main bore 10, while at the same time automatically occluding fluid communication between the primary fluid source and the patient, as well as occluding communication between the primary fluid source and the opening 94 of the luer cannula 35. During injection, this automatically prevents reflux of fluid upstream toward the primary fluid source and assures that the injected fluid is injected toward the patient. During aspiration, this assures that aspiration will come from the patient and not from the primary fluid source. The flow deflector 110 can also be sized so that it is engaged by the distal end 61 ′ of the septum piston 60 ′ to prevent excessive advancement of septum piston 60′, thereby also functioning as a septum piston stop.
In another embodiment (FIG. 9), the septum piston 60″ is shorter and a soft deadspace filler 140″ is provided. The deadspace filler can be of the type and design for use with very blunt cannulae as discussed in my U.S. Pat. No. 5,178,607 (the disclosure of which is hereby incorporated by reference as if completely disclosed herein). The soft outer filler 140″ serves to minimize kickback of the luer taper cannula 35 and functions as a deadspace occluder or displacer. The soft filler 140″ can be comprised of foam rubber which can be covered by a medical grade silicone of the type similar to that used in foam cuffs sold by the Bavona Corporation for tracheostomy tubes or can be otherwise constructed to have a similar ease compressibility and relatively low volume in the compressed state and high volume in the resting non-compressed state. The soft portion 140″ provides a central perforation 152″ for receiving the luer taper cannula 35 through the portion 140″ and subsequently into contact with the less easily compressible septum piston 60″. Although it is preferred that the two portions be bonded together, they may be separate and the proximal portion may be bonded to the proximal inner walls 42 or the cylinder end 30 or may include an umbrella of the type shown in
It should be clear that alternative configurations of the septum piston are possible within the scope of the present invention. For example, at least a portion of the septum piston may be elliptical in cross-section, with the long transverse axis of the slit aligned with the long axis of the ellipse, and with the projecting septum piston compressing members being aligned with the long axis of the ellipse. This configuration could result in enhanced opening of the slit. The septum piston could be otherwise distorted, either longitudinally or horizontally, in association with longitudinal displacement to achieve an open fluid path. It is, however, preferable that this open fluid path extend through the septum piston and directly in contact with the bore of the luer taper cannula so as to facilitate flow and to absolutely minimize the trapping of fluid or blood within the valve.
Although an elastic membranous boot is shown, a perforated deadspace filler, of the type previously discussed with a compressed low displacement volume, may be used to fill the bore of the station and to receive and cover the luer taper.
It is considered advantageous, as with the present invention, to provide a central perforation and flow channel which will be automatically aligned with the bore of the luer taper, since the end of the luer taper cannula can provide a seal against the upper surface of the septum piston adjacent the perforation to minimize leakage of fluid into the proximal bore portion during operation. It is clear that many modifications may be made to the disclosed embodiment. For example, it can be seen that it is possible for a portion of the distal septum piston to have a fixed relationship to the distal bore portion and for a proximal portion of septum piston to simply compress, rather to be actually displaced. In other words, the septum piston could include a portion which extended into the distal bore portion and which had a fixed relationship to the distal bore portion. In this embodiment, a portion of the septum piston within the proximal bore portion would therefore be compressed into the distal bore portion, despite the fixed position of the distal septum piston within the distal bore portion. In either case, the device functions in a similar manner to achieve longitudinal displacement of at least a portion of the mass of the septum piston along the bore to achieve opening of a centrally-oriented flow channel by lateral compression or otherwise by distorting the septum piston. Although the presently preferred embodiments of this invention have been described, it will be obvious to those skilled in the art that various changes and modifications may be made therein without departing from the invention. Therefore, the claims are intended to include all such changes and modifications which may be made therein without departing from the invention. Therefore, the claims are intended to include all such changes and modifications that fall within the true spirit and scope of the invention.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2546672||Jul 10, 1948||Mar 27, 1951||Tecalemit Ltd||Nipple or lubricant-receiving device|
|US3577992||Aug 31, 1967||May 11, 1971||Brunswick Corp||Valve for use with a conduit having a lumen|
|US3659587 *||Jun 30, 1970||May 2, 1972||Affiliated Hospital Prod||Valved connector arrangement|
|US3986508 *||Nov 6, 1974||Oct 19, 1976||Abcor, Inc.||Sterilizable, medical connector for blood processing|
|US4197848 *||Jan 6, 1978||Apr 15, 1980||Baxter Travenol Laboratories, Inc.||Closed urinary irrigation site|
|US4214779 *||Feb 24, 1978||Jul 29, 1980||Gambro Ab||Coupling device|
|US4496350 *||Jun 23, 1983||Jan 29, 1985||Renal Systems, Inc.||Blood access device|
|US4511359 *||Sep 29, 1982||Apr 16, 1985||Manresa, Inc.||Sterile connection device|
|US4685654||Jan 8, 1987||Aug 11, 1987||Hu Liang Tung||Flow regulator for drip infusion|
|US4758225 *||Nov 7, 1986||Jul 19, 1988||Pharmacia Limited||Devices for sampling, drainage or infusion of liquids from or to the human or animal body|
|US4763648 *||Sep 12, 1986||Aug 16, 1988||Migada, Inc.||Method and apparatus for arterial and venous blood sampling|
|US4768568 *||Jul 7, 1987||Sep 6, 1988||Survival Technology, Inc.||Hazardous material vial apparatus providing expansible sealed and filter vented chambers|
|US4809679||Oct 13, 1987||Mar 7, 1989||Olympus Optical Co., Ltd.||Forceps plug for endoscopes|
|US4834152 *||Jul 27, 1987||May 30, 1989||Intelligent Medicine, Inc.||Storage receptacle sealing and transfer apparatus|
|US4929235 *||Jul 31, 1985||May 29, 1990||Universal Medical Instrument Corp.||Self-sealing percutaneous tube introducer|
|US4950257 *||Sep 15, 1988||Aug 21, 1990||Mallinckrodt, Inc.||Catheter introducer with flexible tip|
|US4981469 *||Apr 18, 1988||Jan 1, 1991||Dij Catheter Corp.||Septum adapter assembly and external needle adapter fitting|
|US4998927 *||Aug 18, 1989||Mar 12, 1991||Vaillancourt Vincent L||Connector|
|US5100394||Oct 23, 1989||Mar 31, 1992||Baxter International Inc.||Pre-slit injection site|
|US5108380 *||Jan 4, 1991||Apr 28, 1992||B. Braun Melsungen Ag||Hub member|
|US5114400 *||Jun 19, 1990||May 19, 1992||Lynn Lawrence A||Blood withdrawal apparatus and method|
|US5147305 *||Oct 3, 1991||Sep 15, 1992||Olympus Optical Co., Ltd.||Medical instrument and valve to be mounted on a mount piece of that instrument|
|US5149327 *||Aug 15, 1990||Sep 22, 1992||Terumo Kabushiki Kaisha||Medical valve, catheter with valve, and catheter assembly|
|US5163922 *||Apr 29, 1991||Nov 17, 1992||Charles E. McElveen, Jr.||Dual-valved connector for intravenous systems|
|US5178607||Oct 10, 1990||Jan 12, 1993||Lynn Lawrence A||Blood aspiration assembly septum and blunt needle aspirator|
|US5199948||May 2, 1991||Apr 6, 1993||Mcgaw, Inc.||Needleless valve|
|US5201725 *||Sep 26, 1991||Apr 13, 1993||Ivac||Needle free i.v. adapter|
|US5203775||Mar 20, 1992||Apr 20, 1993||Medex, Inc.||Needleless connector sample site|
|US5211370 *||Jan 6, 1992||May 18, 1993||Powers Ronald J||Variable orifice sealing valve|
|US5211638||Jan 21, 1992||May 18, 1993||Baxter International Inc.||Pre-slit injection site|
|US5215537 *||Sep 13, 1990||Jun 1, 1993||Lynn Lawrence A||Septum for a blunt cannula|
|US5215538 *||Feb 5, 1992||Jun 1, 1993||Abbott Laboratories||Connector-activated in-line valve|
|US5221271||Aug 15, 1991||Jun 22, 1993||Medex, Inc.||Sample site with flow directors|
|US5242432 *||Sep 26, 1991||Sep 7, 1993||Ivac||Needleless adapter|
|US5251873 *||Jun 4, 1992||Oct 12, 1993||Vernay Laboratories, Inc.||Medical coupling site|
|US5273533 *||Mar 11, 1992||Dec 28, 1993||Care Medical Products, Inc.||Medical valve|
|US5295657||Apr 12, 1993||Mar 22, 1994||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5295658||Jun 1, 1993||Mar 22, 1994||Vernay Laboratories, Inc.||Medical coupling site including slit reinforcing members|
|US5300034||Jul 29, 1992||Apr 5, 1994||Minnesota Mining And Manufacturing Company||Iv injection site for the reception of a blunt cannula|
|US5356396||Sep 29, 1992||Oct 18, 1994||Medical Associates Network Inc.||Infusion apparatus|
|US5360413 *||May 19, 1993||Nov 1, 1994||Filtertek, Inc.||Needleless access device|
|US5390898 *||Apr 6, 1994||Feb 21, 1995||Habley Medical Technology Corporation||Needleless dual direction check valve|
|US5396925 *||Dec 16, 1993||Mar 14, 1995||Abbott Laboratories||Anti-free flow valve, enabling fluid flow as a function of pressure and selectively opened to enable free flow|
|US5402982||Sep 20, 1993||Apr 4, 1995||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5403293||Jan 3, 1994||Apr 4, 1995||Abbott Laboratories||Molded partial pre-slit reseal|
|US5405331||Jun 4, 1993||Apr 11, 1995||Minnesota Mining And Manufacturing Company||IV injection site and system|
|US5417673||Apr 21, 1994||May 23, 1995||Medex, Inc.||Whole blood sample needleless sample site|
|US5441487 *||Jan 23, 1995||Aug 15, 1995||Medex, Inc.||Plastic needleless valve housing for standard male luer locks|
|US5449145 *||Oct 8, 1993||Sep 12, 1995||Surgin Surgical Instrumentation, Inc.||Valve device for controlling flows in surgical applications|
|US5466219||Aug 27, 1992||Nov 14, 1995||Lawrence A. Lynn||Blood aspiration assembly components and blunt needle aspirators|
|US5474544||Nov 22, 1994||Dec 12, 1995||Lynn; Lawrence A.||Luer-receiving medical valve|
|US5501426||May 10, 1994||Mar 26, 1996||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5533708||Jan 26, 1995||Jul 9, 1996||Vernay Laboratories, Inc.||Medical coupling site valve body|
|US5603706||Apr 19, 1994||Feb 18, 1997||Wyatt; Philip||Infusion apparatus|
|US5632735||May 11, 1995||May 27, 1997||Wyatt; Philip||Infusion apparatus|
|US5694686||Jun 24, 1994||Dec 9, 1997||Icu Medical, Inc.||Method for assembling a medical valve|
|US5697915||May 30, 1996||Dec 16, 1997||Lynn; Lawrence A.||Displacement-activated medical check valve|
|US5699821||Aug 15, 1994||Dec 23, 1997||Paradis; Joseph R.||Control of fluid flow|
|US5749861||Feb 26, 1997||May 12, 1998||Industrie Borla S.P.A.||Connector with protection valve for medical infusion/transfusion lines and the like|
|US5797897||Jun 6, 1995||Aug 25, 1998||Baxter International Inc.||Pre-slit injection site and tapered cannula|
|US5820601||Aug 20, 1996||Oct 13, 1998||Critical Device Corporation||Needleless injection site|
|US5871500||Jan 5, 1996||Feb 16, 1999||Baxter International Inc.||Pre-slit injection site and tapered cannula|
|USRE35841||Oct 11, 1994||Jul 7, 1998||Medex, Inc.||Needleless connector sample site|
|WO1990011103A2||Mar 16, 1990||Oct 4, 1990||Baxter Int||Pre-slit injection site and tapered cannula|
|WO1998052631A1||May 20, 1998||Nov 26, 1998||Baxter Int||Needleless connector|
|1||Brochure by McGraw, "The Clave"(TM) IV Administration.|
|2||*||Sample of Buron One-Way Valve System.|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7753338||Oct 22, 2007||Jul 13, 2010||Baxter International Inc.||Luer activated device with minimal fluid displacement|
|US7841581||May 5, 2008||Nov 30, 2010||Thorne Consulting & Intellectual Property, LLC||Needle-free medical connector|
|US7842026||Dec 28, 2006||Nov 30, 2010||Nmt Medical, Inc.||Syringe activated-valve for flushing a catheter and methods thereof|
|US7875020||May 18, 2009||Jan 25, 2011||Baxa Corporation||Sterile docking apparatus and method|
|US7896863||Jun 18, 2008||Mar 1, 2011||Tyco Healthcare Group Lp||Positive displacement fluid lock port|
|US7981090||Oct 18, 2006||Jul 19, 2011||Baxter International Inc.||Luer activated device|
|US8100885||Dec 18, 2008||Jan 24, 2012||Tyco Healthcare Group Lp||Cap assembly for use with a prefilled lock solution syringe|
|US8221363||Oct 18, 2006||Jul 17, 2012||Baxter Healthcare S.A.||Luer activated device with valve element under tension|
|US8382741||Feb 16, 2011||Feb 26, 2013||Covidien Lp||Positive displacement fluid lock port|
|US8496643||Dec 22, 2011||Jul 30, 2013||Covidien Lp||Cap assembly for use with a prefilled lock solution syringe|
|US8771230||May 19, 2011||Jul 8, 2014||Tangent Medical Technologies, Llc||Integrated vascular delivery system|
|US8795240||Feb 16, 2011||Aug 5, 2014||Covidien Lp||Positive displacement fluid lock port|
|US8814833||May 19, 2011||Aug 26, 2014||Tangent Medical Technologies Llc||Safety needle system operable with a medical device|
|US20070078443 *||May 10, 2006||Apr 5, 2007||Gerry Tighe||Sterile docking apparatus and method|
|US20070179474 *||Dec 28, 2006||Aug 2, 2007||Cahill Ryan J||Syringe activated-valve for flushing a catheter and methods thereof|
|US20080172004 *||Oct 18, 2006||Jul 17, 2008||Michael Plishka||Luer activated device with stretchable valve element|
|US20090005759 *||Jun 18, 2008||Jan 1, 2009||Tyco Healthcare Group Lp||Positive displacement fluid lock port|
|US20090057589 *||May 5, 2008||Mar 5, 2009||Thorne Consulting And Intellectual Property, Llc||Needle-free medical connector|
|US20090163876 *||Dec 18, 2008||Jun 25, 2009||Tyco Healthcare Group Lp||Cap Assembly for Use With a Prefilled Lock Solution Syringe|
|US20090306628 *||Dec 10, 2009||Baxa Corporation||Sterile docking apparatus and method|
|US20110137264 *||Jun 9, 2011||Tyco Healthcare Group Lp||Positive Displacement Fluid Lock Port|
|US20110137265 *||Jun 9, 2011||Tyco Healthcare Group Lp||Positive Displacement Fluid Lock Port|
|U.S. Classification||604/533, 604/167.01, 251/334, 604/33|
|International Classification||A61M39/26, A61M39/02, A61M39/20, A61M39/00, A61M39/04, A61M5/24|
|Cooperative Classification||A61J1/2044, A61J1/2058, A61M39/26, A61M39/20, A61M39/045, A61M39/02, A61J1/2096|